Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndrome

Heart Rhythm. 2012 Jul;9(7):1143-7. doi: 10.1016/j.hrthm.2012.02.006. Epub 2012 Feb 7.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Contraceptive Agents, Female / adverse effects*
  • Defibrillators, Implantable
  • Delayed-Action Preparations
  • Female
  • Heart Conduction System / physiopathology
  • Humans
  • Hypodermoclysis
  • Injections, Intramuscular
  • Long QT Syndrome / congenital
  • Long QT Syndrome / genetics
  • Long QT Syndrome / physiopathology
  • Medroxyprogesterone Acetate / administration & dosage
  • Medroxyprogesterone Acetate / adverse effects*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular
  • Pregnancy Outcome
  • Progesterone / physiology
  • Prosthesis Failure
  • Tachycardia, Ventricular / etiology
  • Torsades de Pointes / chemically induced*
  • Torsades de Pointes / complications*
  • Torsades de Pointes / physiopathology

Substances

  • Contraceptive Agents, Female
  • Delayed-Action Preparations
  • Progesterone
  • Medroxyprogesterone Acetate